Pirfenidone in Adult Hospitalized Patients With COVID-19

Clinical trial NCT05713292 · COMPLETED

Trial details

NCT number: NCT05713292
Sponsor: Capital Medical University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Pneumonia

Start date: 2022-12-01
Primary completion: 2023-03-04
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.